Home / Going-concern warnings / Replimune Group, Inc.
Filed 2026-08-14 路 Form 10-Q 路 Accession 0001628280-26-057099 small
Price before filing: $15.19 (2026-08-13 close, split/dividend-adjusted)
Market cap at flag: $1.45B (2026-08-14) 路 Latest: $1.05B (2026-10-16)
| Window | REPL | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -13.7% | -2.2% | -11.5% | 2026-09-14 |
| 90 days | pending | pending | until 2026-11-12 | |
| 180 days | pending | pending | until 2027-02-10 | |
| 1 year | pending | pending | until 2027-08-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 6 insiders sold $1.5M (11 sales)
30 days after: 1 insider sold $132K (1 sale)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Astley-Sparke Philip Director | Sale | 17,657 | $5.08 | $90K | no | Form 4 |
| 2026-05-18 | Hill Emily Luisa Chief Financial Officer | Sale | 7,812 | $5.08 | $40K | no | Form 4 |
| 2026-05-18 | Patel Sushil Chief Executive Officer, Director | Sale | 37,324 | $5.08 | $190K | no | Form 4 |
| 2026-05-18 | Sarchi Christopher Chief Commercial Officer | Sale | 8,626 | $5.08 | $44K | no | Form 4 |
| 2026-05-18 | Schwendenman Andrew Chief Accounting Officer | Sale | 7,894 | $5.08 | $40K | no | Form 4 |
| 2026-05-18 | Xynos Konstantinos Chief Medical Officer | Sale | 14,023 | $5.08 | $71K | no | Form 4 |
| 2026-06-01 | Sarchi Christopher Chief Commercial Officer | Sale | 12,000 | $9.24 | $111K | yes | Form 4 |
| 2026-08-10 | Hill Emily Luisa Chief Financial Officer | Sale | 11,448 | $12.97 | $148K | no | Form 4 |
| 2026-08-10 | Patel Sushil Chief Executive Officer, Director | Sale | 39,341 | $12.97 | $510K | no | Form 4 |
| 2026-08-10 | Schwendenman Andrew Chief Accounting Officer | Sale | 7,632 | $12.97 | $99K | no | Form 4 |
| 2026-08-10 | Xynos Konstantinos Chief Medical Officer | Sale | 11,447 | $12.97 | $148K | no | Form 4 |
| 2026-08-14: red flag filed | |||||||
| 2026-08-17 | Hill Emily Luisa Chief Financial Officer | Sale | 9,256 | $14.28 | $132K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-05-16 to 2026-09-13. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"The conditions that raised substantial doubt have been subsequently alleviated, as the Company raised approximately $ 141.0 million in net proceeds from an equity offering in August 2026."
Quoted from the filing. Source
Going-concern doubt disclosed, then alleviated: the company said conditions raised substantial doubt about its ability to continue as a going concern, but that its plans or new funding resolve that doubt for the next 12 months. A weaker warning than an unresolved going-concern doubt, but the company recently needed a rescue plan or fresh money to stay afloat.
Source: management disclosure in Form 10-Q (period 2026-06-30)
Status: doubt alleviated (the company says its plans or new funding resolve the substantial doubt it disclosed)
Why this score: substantial doubt disclosed, then alleviated by management's plans or new funding; quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.